Gabriel Holdsman is the Global General Counsel for a pharmaceutical company dedicated to the discovery, development, and commercialization of medicines that benefit patients with rare diseases. A trusted leader and strategic business partner, he is recognized for driving high performance with unwavering integrity.
Gabriel’s responsibilities span a wide range of corporate, legal, and operational functions, including corporate governance, board support, securities, risk management, cybersecurity, M&A, regulatory compliance, FDA oversight, and healthcare compliance. He brings deep expertise across pharmaceuticals, biologics, medical devices, and gene therapy, supporting functions from R&D and clinical trials to sales, marketing, supply chain, and manufacturing.
A Gallup-certified manager, Gabriel excels at team building and fostering inclusive workplaces, with a strong focus on Diversity & Inclusion and LGBTQ+ initiatives. He also advises on business development, licensing, collaboration, co-promotion agreements, investigations, and litigation—ensuring legal and ethical rigor while supporting strategic business growth in the rare disease sector.